Cannabinoid Vaping Products, Genomic Biomarkers, a Novel In Vitro Testing System, and More in New Toxicological Sciences

Cannabinoid vaping products, genomic biomarkers to determine tumorigenic potential, and analyses of various testing assays are just a few of the article topics in the July 2022 issue of Toxicological Sciences.

This issue features a ToxPoint article arguing that “Cannabinoid Vaping Products Present Novel Challenges for Assessment of Respiratory Health Effects,” as well as a Forum article looking at “A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies.”

The July issue also includes two ToxSpotlight articles:

• “Effects of Serum and Compound Preparation Methods on Delayed Repolarization Evaluation With Human iPSC-CMs”
• “Low-Dose Cadmium Potentiates Metabolic Reprogramming Following Early-Life Respiratory Syncytial Virus Infection”

Visit the ToxSci website to view the full July 2022 issue.